Ontario Investing $5 Million to Strengthen Province’s Position as a Global Leader in Life Sciences

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

We appreciate the government’s $5 Million investment through the fourth round of the Life Sciences Innovation Fund (LSIF), strengthening Ontario’s position as a global leader in life sciences. Life Sciences Innovation Fund will help 10 companies create good-paying jobs and commercialize innovative medical technologies. Congratulations to the ten recipient companies!

We are delighted to share that nine of the selected companies - Esphera SynBio, Kare Chemical Technologies, Myomar Molecular, myStoria, mDETECT, NodeAI, Stoked Bio, Synakis, and Synmedix - are OBIO‑affiliated, and we are proud to be part of their journey!

Read more
Arsheen Kaur
Previous

Diamond Therapeutics Receives Multi-Million Dollar US Government Funding for Phase 2 Clinical Trial of Anxiety Treatment
Next

OBIO® and IPON renew multi-year collaboration to advance Ontario’s sovereign IP capacity